Friends! In this video, I will reveal the best growth stock to buy in this market.
2 extracted signals · 2 resolved · 0 still active
The Patient InvestorIndependent analyst profile- Source published
- 13 Aug 2025, 22:21 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC

AI-generated source summary
The presenter discusses two growth stocks, SOFI, currently priced at $23.65, the presenter predicts will reach $32.00 within a year, and HIMS, as of the current date trading at $47.96, the presenter estimates a target value of $65.00 within the next year, due to GLP-1 and telehealth opportunities. He supports that HIMS having a great potential and profitability with revenue estimates pointing to a growth is coming in a way to be considered a non factor to be ignored. He also stated that the fail bound to HIMS would be around 40 dollars.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
2 eligible signals linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
The Patient Investor
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

